Meeting
2022 ASCO Genitourinary Cancers Symposium
Characteristics and outcomes of patients managed with surgical resection of brain metastasis from renal cell carcinoma.
Authors
Max Drescher
University of Maryland, Baltimore, MD
Max Drescher , Sunil H. Patel , Ridwan Alam , Claire De La Calle , Anirudh Yerrapragada , Chetan Bettegowda , Andres Matoso , Yasser Ged , Nirmish Singla
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Other
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 392)
DOI
10.1200/JCO.2022.40.6_suppl.392
Abstract #
392
Poster Bd #
J11
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Improved survival rates in kidney cancer patients with brain metastases treated with modern multidisciplinary approaches.
First Author: I. Alex Bowman
Poster
2023 ASCO Annual Meeting
INTRAMET: Results of a prospective, single-arm, open-label phase II trial of intraoperative radiotherapy after resection of brain metastases.
First Author: Stefanie Brehmer
Poster
2022 ASCO Annual Meeting
Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
First Author: Jennifer Ma
Poster
2017 Gastrointestinal Cancers Symposium
Incidence of brain metastasis from esophageal cancer.
First Author: Jonathan Ben Ashman